Details der Publikation - This Week in the Journal

This Week in the Journal

Results showed no between-group difference in disability outcomes. see (Original Article, N Engl J Med 2017;376:2437-2447) Glucocorticoid-Sparing Effect of Benralizumab in Asthma The use of benralizumab, a monoclonal antibody directed against the alpha subunit of the interleukin-5 receptor, allowed patients with asthma who were dependent on oral glucocorticoids to reduce the glucocorticoid dose to a greater extent than those who received placebo. see (Original Article, N Engl J Med 2017;376:2448-2458) Post-Traumatic Stress Disorder PTSD is....

Medienart:	Artikel

Erscheinungsjahr:	2017
Erschienen:	2017

Enthalten in:	Zur Gesamtaufnahme - volume:376
Enthalten in:	The New England journal of medicine - 376(2017), 25, Seite 2414

Sprache:	Englisch

Links:	search.proquest.com

BKL:	44.60 44.00
Themen:	Asthma Chemotherapy Citation indexes Clinical medicine Health care policy Health risk assessment Imprisonment Influenza Lung cancer Mastectomy Post traumatic stress disorder Tumors

RVK:	RVK Klassifikation XA 10000

Förderinstitution / Projekttitel:

PPN (Katalog-ID):	OLC1996233122

Internformat


LEADER	01000caa a2200265 4500
001	OLC1996233122
003	DE-627
005	20230513085336.0
007	tu
008	170901s2017 xx \|\|\|\|\| 00\| \|\|eng c
028	5	2	\|a PQ20171125
035			\|a (DE-627)OLC1996233122
035			\|a (DE-599)GBVOLC1996233122
035			\|a (PRQ)proquest_journals_19196429580
035			\|a (KEY)0171808820170000376002502414thisweekinthejournal
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
082	0	4	\|a 610 \|q DE-101
084			\|a XA 10000 \|q AVZ \|2 rvk
084			\|a 44.60 \|2 bkl
084			\|a 44.00 \|2 bkl
245	1	0	\|a This Week in the Journal
264		1	\|c 2017
336			\|a Text \|b txt \|2 rdacontent
337			\|a ohne Hilfsmittel zu benutzen \|b n \|2 rdamedia
338			\|a Band \|b nc \|2 rdacarrier
520			\|a Results showed no between-group difference in disability outcomes. see (Original Article, N Engl J Med 2017;376:2437-2447) Glucocorticoid-Sparing Effect of Benralizumab in Asthma The use of benralizumab, a monoclonal antibody directed against the alpha subunit of the interleukin-5 receptor, allowed patients with asthma who were dependent on oral glucocorticoids to reduce the glucocorticoid dose to a greater extent than those who received placebo. see (Original Article, N Engl J Med 2017;376:2448-2458) Post-Traumatic Stress Disorder PTSD is...
650		4	\|a Imprisonment
650		4	\|a Health care policy
650		4	\|a Influenza
650		4	\|a Post traumatic stress disorder
650		4	\|a Chemotherapy
650		4	\|a Citation indexes
650		4	\|a Asthma
650		4	\|a Health risk assessment
650		4	\|a Mastectomy
650		4	\|a Tumors
650		4	\|a Clinical medicine
650		4	\|a Lung cancer
773	0	8	\|i Enthalten in \|t The New England journal of medicine \|d Waltham, Mass. : MMS, 1928 \|g 376(2017), 25, Seite 2414 \|w (DE-627)129495220 \|w (DE-600)207154-X \|w (DE-576)014893169 \|x 0028-4793 \|7 nnns
773	1	8	\|g volume:376 \|g year:2017 \|g number:25 \|g pages:2414
856	4	2	\|u https://search.proquest.com/docview/1919642958
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_OLC
912			\|a SSG-OLC-PHA
912			\|a SSG-OLC-DE-84
912			\|a GBV_ILN_20
912			\|a GBV_ILN_40
912			\|a GBV_ILN_105
912			\|a GBV_ILN_168
912			\|a GBV_ILN_183
912			\|a GBV_ILN_290
912			\|a GBV_ILN_2004
912			\|a GBV_ILN_2006
912			\|a GBV_ILN_2008
912			\|a GBV_ILN_2021
912			\|a GBV_ILN_2219
912			\|a GBV_ILN_2414
912			\|a GBV_ILN_2424
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4219
912			\|a GBV_ILN_4256
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4310
912			\|a GBV_ILN_4315
912			\|a GBV_ILN_4320
912			\|a GBV_ILN_4323
936	r	v	\|a XA 10000
936	b	k	\|a 44.60 \|q AVZ
936	b	k	\|a 44.00 \|q AVZ
951			\|a AR
952			\|d 376 \|j 2017 \|e 25 \|h 2414

This Week in the Journal

Zugang & Verfügbarkeit

Zugehörige Publikationen/Bände